Masimo (NASDAQ:MASI) Now Covered by Analysts at Loop Capital

Loop Capital assumed coverage on shares of Masimo (NASDAQ:MASIGet Rating) in a report published on Tuesday, The Fly reports. The firm issued a buy rating on the medical equipment provider’s stock.

MASI has been the subject of a number of other research reports. Needham & Company LLC lifted their price objective on Masimo from $163.00 to $179.00 and gave the company a buy rating in a research note on Wednesday, August 10th. Piper Sandler lifted their price objective on Masimo from $130.00 to $135.00 and gave the company a neutral rating in a research note on Wednesday, August 10th. StockNews.com cut Masimo from a buy rating to a hold rating in a research note on Wednesday, August 10th. Finally, Stifel Nicolaus boosted their price target on Masimo from $162.00 to $172.00 and gave the stock a buy rating in a research note on Monday. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $188.20.

Masimo Trading Down 6.5 %

NASDAQ MASI opened at $146.37 on Tuesday. The company has a quick ratio of 1.28, a current ratio of 2.10 and a debt-to-equity ratio of 0.77. Masimo has a twelve month low of $112.07 and a twelve month high of $305.21. The firm has a market capitalization of $7.69 billion, a PE ratio of 44.09 and a beta of 0.96. The stock’s 50 day moving average is $146.33 and its 200 day moving average is $141.20.

Masimo (NASDAQ:MASIGet Rating) last released its quarterly earnings results on Tuesday, August 9th. The medical equipment provider reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.16. The company had revenue of $565.30 million for the quarter, compared to analyst estimates of $540.56 million. Masimo had a return on equity of 17.39% and a net margin of 12.68%. The firm’s revenue was up 87.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.94 earnings per share. Research analysts forecast that Masimo will post 4.47 earnings per share for the current fiscal year.

Institutional Trading of Masimo

Hedge funds have recently bought and sold shares of the company. Center for Financial Planning Inc. purchased a new stake in Masimo during the first quarter valued at $29,000. Meeder Asset Management Inc. increased its position in Masimo by 61.3% during the second quarter. Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 84 shares during the last quarter. Itau Unibanco Holding S.A. purchased a new stake in Masimo during the fourth quarter valued at $80,000. Parallel Advisors LLC increased its position in Masimo by 38.8% during the second quarter. Parallel Advisors LLC now owns 365 shares of the medical equipment provider’s stock valued at $48,000 after acquiring an additional 102 shares during the last quarter. Finally, Archer Investment Corp grew its holdings in Masimo by 62.2% during the second quarter. Archer Investment Corp now owns 391 shares of the medical equipment provider’s stock valued at $51,000 after purchasing an additional 150 shares during the period. Hedge funds and other institutional investors own 93.31% of the company’s stock.

About Masimo

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Articles

The Fly logo

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.